Abiopharma

The subsidiary Ness (98%) in an agreement to purchase all holdings in Log-On Ltd. and Log-On’s subsidiary and sub-subsidiary for approximately NIS 164.5 million, details, subject to

Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage

Register of shareholders, changes and share capital status – exercise of warrants (series 4) into shares

10x Genomics - 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments

Compass Pathways - Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments

Rosen Law Firm Encourages Green Circle Decarbonize Technology Ltd. Investors to Inquire About Securities Class Action Investigation – GCDT

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026